Loading...
OTCM
ELVAF
Market cap7mUSD
Nov 08, Last price  
0.90USD
Name

Evolva Holding SA

Chart & Performance

D1W1MN
OTCM:ELVAF chart
No data to show
P/E
—
P/S
0.48
EPS
—
Div Yield, %
—
Shrs. gr., 5y
11.85%
Rev. gr., 5y
1.11%
Revenues
9m
-39.27%
0273,560164,510424,40418,926,68718,628,53011,080,2217,014,4428,706,20010,744,30013,363,6009,575,7006,846,7008,932,60011,596,0007,540,7009,877,60015,539,4009,437,800
Net income
-105m
L+142.65%
-35,042,040-72,530,960-59,120,280-66,451,549-9,608,907-23,298,866-22,451,971-16,089,948-15,731,900-21,352,900-31,891,900-35,970,700-38,976,900-29,213,900-21,638,900-29,870,200-41,266,400-43,366,400-105,229,400
CFO
-2m
L-73.64%
-34,405,780-53,947,330-59,087,490-44,535,168-5,933,657-15,831,343-17,402,435-13,445,766-12,523,800-19,943,700-31,729,200-33,852,300-35,572,900-23,607,000-14,160,500-23,362,700-29,789,200-18,880,700-9,254,500-2,439,300
Earnings
Apr 11, 2025

Profile

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
URL
https://www.evolva.com/
IPO date
May 04, 2005
Employees
50
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
9,438
-39.27%
15,539
57.32%
Cost of revenue
51,386
38,898
Unusual Expense (Income)
NOPBT
(41,948)
(23,359)
NOPBT Margin
Operating Taxes
7,862
Tax Rate
NOPAT
(41,948)
(31,221)
Net income
(105,229)
142.65%
(43,366)
5.09%
Dividends
Dividend yield
Proceeds from repurchase of equity
6,046
BB yield
Debt
Debt current
12,151
Long-term debt
5,814
Deferred revenue
Other long-term liabilities
100
1,579
3,196
Net debt
(6,753)
(5,839)
10,749
Cash flow
Cash from operating activities
(2,439)
(9,254)
(18,881)
CAPEX
(2,253)
Cash from investing activities
3,517
15,949
(1,764)
Cash from financing activities
(163)
(5,973)
14,766
FCF
1,293
(19,512)
(34,400)
Balance
Cash
6,753
5,839
5,143
Long term investments
2,073
Excess cash
6,753
5,367
6,439
Stockholders' equity
(467,979)
5,570
(266,512)
Invested Capital
474,576
1,765
391,004
ROIC
ROCE
EV
Common stock shares outstanding
5,396
4,281
Price
Market cap
EV
EBITDA
(37,367)
(15,268)
EV/EBITDA
Interest
2,291
761
Interest/NOPBT